Related Experiment Video
Updated: Jul 24, 2026
13:34
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Structure-activity studies on gossypol in tumor cell lines.
M D Shelley1, L Hartley, P W Groundwater
1Research Laboratories, Velindre NHS Trust, Whitchurch, Cardiff, UK. mike.shelley@velindre.tr.wales.nhs.uk
Anti-Cancer Drugs
|June 1, 2000
Summary
Gossypol, a cotton plant compound, shows anti-tumor activity. Structure-activity studies reveal that one aldehyde group is crucial for its cytotoxicity against various cancer cells, regardless of stereochemistry.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Cancer Biology
Background:
- Gossypol (1a) is a naturally occurring cotton plant compound with established anti-tumor properties.
- Previous research highlighted gossypol's potential as an oral male contraceptive and its anti-cancer activity in preclinical and clinical studies.
- The role of specific functional groups in gossypol's biological activity, particularly its anti-tumor effects, warrants detailed investigation.
Purpose of the Study:
- To investigate the structure-activity relationship of gossypol derivatives concerning their anti-tumor effects.
- To determine the importance of the aldehyde functional groups and stereochemistry in gossypol's cytotoxicity.
- To evaluate the anti-cancer potential of gossypol and its modified analogs in various human cancer cell lines.
Main Methods:
- Synthesis and evaluation of four racemic compounds: gossypol (1a), gossypolone (2), bis Schiff's base (1c), and apogossypol (1b).
- Testing of enantiomers (l- and d-isomers) of gossypol (1a) and its derivatives, including a half Schiff's base (1d).
- Cytotoxicity assessment using MTT and flow cytometric viability assays across melanoma, cervix, small cell lung, and myelogenous leukemia cell lines.
Main Results:
- Racemic gossypol (1a) and gossypolone (2), retaining aldehyde groups, exhibited significant dose-dependent cytotoxicity (IC50: 23-50 microM) across all tested cell lines.
- Apogossypol (1b) and the bis Schiff's base derivative (1c), with blocked or absent aldehydes, showed minimal anti-cancer activity.
- The l-enantiomer of gossypol was significantly more potent than the d-enantiomer (IC50: 20 vs. >50 microM), and blocking one aldehyde (1d) maintained high cytotoxicity.
Conclusions:
- The presence of at least one aldehyde group is essential for the cytotoxic activity of gossypol against tumor cells.
- Gossypol's anti-tumor efficacy is influenced by stereochemistry, with the l-enantiomer being more active.
- These findings underscore the importance of the aldehyde functional groups in gossypol's anti-cancer mechanism and guide future drug design.
